Shares of Intercept Pharmaceuticals Inc (NASDAQ:ICPT) tagged a double bottom support level yesterday at $58.00. They then reversed and could be putting in a bottoming tail. This may give swing traders an opportunity to buy for a near-term pop. Being a biotech, Intercept Pharma carries more risk but also more reward. Look for a potential pop back towards $85.00.